🩺 Latent Autoimmune Diabetes in Adults (LADA): The Diabetes That’s Often Misdiagnosed

You’ve been told you have Type 2 diabetes, but something doesn’t add up. You’re not overweight, you’re losing weight, and the pills aren’t working. You may be one of the many adults who actually have Latent Autoimmune Diabetes in Adults (LADA) — a slowly progressive form of autoimmune diabetes that looks a lot like Type 2 but is fundamentally different. Dr. Ravi Sishir Reddy explains what LADA is, how to distinguish it from Type 2, and why the correct diagnosis matters for your treatment and long‑term health.

1. What Is LADA?

LADA is a form of autoimmune diabetes in which the body’s immune system slowly attacks and destroys the insulin‑producing beta cells in the pancreas, just like in classic Type 1 diabetes. However, the destruction is much slower, and patients are typically diagnosed after the age of 30. Because of this, LADA is often mistaken for Type 2 diabetes. In fact, up to 10% of adults diagnosed with Type 2 diabetes may actually have LADA.

The key feature: LADA patients are initially able to manage without insulin, often for months to years, but they have autoantibodies (such as anti‑GAD) that mark the autoimmune process. Over time — usually within 6 months to 6 years — they become insulin‑dependent as beta‑cell function declines.

2. LADA vs. Type 1 vs. Type 2 Diabetes

Feature	Type 1	LADA	Type 2
Typical age of onset	Childhood / adolescence	>30 years	>40 years (now younger)
Body habitus	Usually lean	Usually lean / normal weight	Often overweight / obese
Autoantibodies (anti‑GAD, etc.)	Positive	Positive	Negative
C‑peptide / insulin production	Very low or absent	Low (but not absent at diagnosis)	Normal to high (insulin resistance)
Initial need for insulin	Immediate	Not immediate (months‑years)	Often not needed for years
Progression to insulin dependence	Already dependent	Within 6 months‑6 years	Slow; often can be avoided

3. What Are the Clues That You Might Have LADA?

Consider the possibility of LADA if you were diagnosed with Type 2 diabetes but have one or more of the following:

• You are lean or normal weight (BMI < 25) and not typically obese.
• Your blood sugar is difficult to control despite taking multiple oral medications.
• You have a personal or family history of other autoimmune diseases (thyroid disease, celiac disease, vitiligo, pernicious anaemia).
• You are losing weight unintentionally despite eating well.
• Your diabetes was diagnosed at a relatively young age (30‑50) without the typical metabolic syndrome features (high blood pressure, high triglycerides, low HDL).
• Oral diabetes medications, particularly sulfonylureas, seem to stop working quickly.

Dr. Reddy advises that if these features are present, asking your doctor for autoantibody testing (specifically anti‑GAD) is reasonable. A positive result strongly suggests LADA.

4. How Is LADA Diagnosed?

The diagnosis of LADA is based on three criteria:

1. Age > 30 years at diagnosis.
2. Presence of at least one islet autoantibody, most commonly anti‑glutamic acid decarboxylase (anti‑GAD). Anti‑islet cell antibodies (ICA), anti‑insulin antibodies (IAA), and anti‑tyrosine phosphatase (IA‑2) may also be present.
3. No immediate need for insulin at diagnosis (typically for at least 6 months).

A low or declining C‑peptide level (a marker of the body’s own insulin production) further supports the diagnosis and distinguishes LADA from insulin‑resistant Type 2 diabetes, where C‑peptide is often high.

5. Why Does Getting the Right Diagnosis Matter?

Misdiagnosing LADA as Type 2 can lead to suboptimal treatment. Because LADA is an autoimmune disease, some medications used for Type 2 diabetes — particularly sulfonylureas (glimepiride, glibenclamide) — may overstimulate the struggling beta cells and accelerate their destruction, leading to earlier insulin dependence. In contrast, early insulin therapy in LADA has been shown to preserve beta‑cell function and improve long‑term blood sugar control. Metformin can be used, but the key is to recognise the autoimmune nature and plan for insulin when needed.

6. How Is LADA Treated?

There is no standardised drug protocol for LADA, but the following principles apply:

• Insulin therapy: Should be initiated earlier than in typical Type 2 diabetes to protect remaining beta cells. Once C‑peptide declines, basal‑bolus insulin regimens (long‑acting + mealtime insulin) are used, similar to Type 1 diabetes.
• Metformin: Can be continued if there is some degree of insulin resistance, but it does not address the autoimmune process.
• GLP‑1 agonists and SGLT2 inhibitors: May have some beta‑cell protective effects and can be used in early LADA, but should be discussed with an endocrinologist.
• Lifestyle: A balanced diet and regular exercise are important for all forms of diabetes, but they cannot stop the autoimmune destruction.

Ongoing monitoring of C‑peptide levels and autoantibody titres helps guide therapy.